058820.KQ
CMG Pharmaceutical Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 623.00
+7.04%Margins
Gross margin
55.0%
EBITDA margin
3.6%
EBIT margin
-3.1%
Net margin
5.0%
FCF margin
-44.4%
2.8%
Return on equity
1.8%
Return on assets
-1.3%
Return on invested capital
0.36x
Asset turnover
-KRW 10.7B
Cash from operations
KRW 120
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026